Chris Walker

Chris is the Head of Regulatory Affairs for Europe, co-lead of R&D for Europe and the Head of R&D for the UK Sites

As European Regulatory Affairs Head, Chris leads the team that develop and execute the regulatory strategy for Amgen’s portfolio across the European region including Russia, CIS and Israel. He ensures the efficient execution of the strategy, engagement with the regulatory agencies across Europe, and ensures the team influence the regulated environment in which Amgen operates. The European HQ and Affiliate regulatory organizations report to Chris and he is accountable for the CMC, labelling and R&D policy teams.

Chris is the co-lead for R&D in Europe and is an internal and external voice of Amgen for R&D in the region. Chris collaborates closely with the Medical R&D co-lead and together they contribute to the advancement of Amgen’s portfolio and shaping of the European framework for Medicines for the benefit of European patients.

As Head of R&D for the UK sites Chris leads the engagement of the UK based R&D team of over 500 staff across both Cambridge & Uxbridge. This role involves a close partnership with the head of the UK & Ireland Affiliate and the Global R&D leadership network.

Since joining Amgen in 2005 Chris has held several regulatory roles within Amgen based in the UK. Prior to joining Amgen Chris held both Regulatory and Research roles at BPL, who focus on medicinal products derived from human plasma. Chris holds a BSc in Biological Sciences and an MSc in Regulatory Affairs.